insights_auto
Why is HLN down 3.11%?
Dive Deeperchevron_right
HLN:NYSE
Haleon PLC - ADR
$8.72
arrow_downward
-3.11%(-0.28) 1D
$8.73
arrow_upward
+0.11% (+0.0100)bedtimeAfter hours
Closed: Oct 1, 4:00:02 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLN...
Open
$8.93
High
$8.94
Low
$8.67
Mkt. cap
38.06B
Avg. vol.
16.87M
Volume
27.48M
Dividend
2.27%
Quarterly dividend
$0.05
Ex-dividend date
Aug 13, 2026
P/E ratio
18.14
52-wk high
$11.28
52-wk low
$8.65
EPS
$0.48
Beta
0.13
Shares outstanding
4.40B
No. of employees
25K
Open
$8.93
High
$8.94
Low
$8.67
Mkt. cap
38.06B
Avg. vol.
16.87M
Volume
27.48M
Dividend
2.27%
Quarterly dividend
$0.05
Ex-dividend date
Aug 13, 2026
P/E ratio
18.14
52-wk high
$11.28
52-wk low
$8.65
EPS
$0.48
Beta
0.13
Shares outstanding
4.40B
No. of employees
25K
News stories
From web sources and news partners
Timothy Sykes
·
7 hours ago
HLN Stock Slips Onto Negative Watch As Targets Cut
Stock Titan
·
16 hours ago
With 11.8M treasury shares, Haleon (HLN) reports 8.80B shares carrying voting rights.
TipRanks
·
18 hours ago
Haleon Updates Share Capital and Voting Rights Ahead of Disclosure Assessments
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC - ADR